[{"address1": "3300 Bee Cave Road", "address2": "Suite 650-227", "city": "Austin", "state": "TX", "zip": "78746", "country": "United States", "phone": "877 774 4679", "website": "https://www.genprex.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Rodney Varner", "age": 66, "title": "Co-Founder, Chairman, President & CEO", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": 886974, "exercisedValue": 0, "unexercisedValue": 316330}, {"maxAge": 1, "name": "Mr. Ryan M. Confer M.S.", "age": 41, "title": "Chief Financial Officer", "yearBorn": 1982, "fiscalYear": 2022, "totalPay": 606572, "exercisedValue": 0, "unexercisedValue": 79084}, {"maxAge": 1, "name": "Mr. David M. Schloss", "title": "Senior Vice President of Human Resources", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas C. Gallagher Esq.", "title": "Senior Vice President of Intellectual Property & Licensing", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark S. Berger M.D.", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1955, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Suzanne  Thornton-Jones", "title": "Senior Vice President of Regulatory Affairs & Quality", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack A. Roth F.A.C.S., M.D.", "title": "Chairman of Scientific & Medical Advisory Board", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.21, "open": 2.27, "dayLow": 2.18, "dayHigh": 2.27, "regularMarketPreviousClose": 2.21, "regularMarketOpen": 2.27, "regularMarketDayLow": 2.18, "regularMarketDayHigh": 2.27, "beta": -0.633, "forwardPE": -0.7983453, "volume": 17451, "regularMarketVolume": 17451, "averageVolume": 88395, "averageVolume10days": 34470, "averageDailyVolume10Day": 34470, "marketCap": 4240030, "fiftyTwoWeekLow": 2.18, "fiftyTwoWeekHigh": 44.0, "fiftyDayAverage": 3.70918, "twoHundredDayAverage": 13.027145, "currency": "USD", "enterpriseValue": -2497596, "floatShares": 1878155, "sharesOutstanding": 1910440, "sharesShort": 69946, "sharesShortPriorMonth": 64893, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0366, "heldPercentInsiders": 0.00851, "heldPercentInstitutions": 0.06555, "shortRatio": 0.8, "shortPercentOfFloat": 0.037, "impliedSharesOutstanding": 1910440, "bookValue": 4.991, "priceToBook": 0.4446804, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -30860460, "trailingEps": -22.56, "forwardEps": -2.78, "lastSplitFactor": "1:40", "lastSplitDate": 1706832000, "enterpriseToEbitda": 0.08, "52WeekChange": -0.9481542, "SandP52WeekChange": 0.21231294, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "GNPX", "underlyingSymbol": "GNPX", "shortName": "Genprex, Inc.", "longName": "Genprex, Inc.", "firstTradeDateEpochUtc": 1522330200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d506e914-dc7c-30af-b5b9-638e83c34981", "messageBoardId": "finmb_225557674", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.2194, "targetHighPrice": 320.0, "targetLowPrice": 10.0, "targetMeanPrice": 165.0, "targetMedianPrice": 165.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 6737629, "totalCashPerShare": 3.527, "ebitda": -31060566, "quickRatio": 2.07, "currentRatio": 2.314, "returnOnAssets": -1.08639, "returnOnEquity": -2.07877, "freeCashflow": -13901023, "operatingCashflow": -24738604, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-19"}]